Defining Intravenous Recombinant Tissue Plasminogen Activator Failure

被引:7
|
作者
Guerrero, Waldo R. [1 ]
Grotta, James C. [1 ]
机构
[1] Univ Texas Houston, Houston Med Sch, Houston, TX USA
基金
美国国家卫生研究院;
关键词
endovascular treatment; imaging; magnetic resonance imaging; reperfusion; TPA; thrombolysis; transcranial Doppler; ACUTE ISCHEMIC-STROKE; NO EARLY RECANALIZATION; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; INTRAARTERIAL; THROMBOLYSIS; THERAPY; IMPROVEMENT; REVASCULARIZATION; NEPHROPATHY;
D O I
10.1161/STROKEAHA.112.678888
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:819 / 821
页数:3
相关论文
共 50 条
  • [21] Very Early Mobilization in Stroke Patients Treated with Intravenous Recombinant Tissue Plasminogen Activator
    Arnold, Scott M.
    Dinkins, Maryane
    Mooney, Lesia H.
    Freeman, William D.
    Rawal, Bhupendra
    Heckman, Michael G.
    Davis, Olivia A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (06): : 1168 - 1173
  • [22] Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
    Sadeghi-Hokmabadi, Elyar
    Farhoudi, Mehdi
    Taheraghdam, Aliakbar
    Hashemilar, Mazyar
    Savadi-Osguei, Daryous
    Rikhtegar, Reza
    Mehrvar, Kaveh
    Sharifipour, Ehsan
    Youhanaee, Parisa
    Mirnour, Reshad
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 361 - 367
  • [23] Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
    Hirano, Teruyuki
    NEUROLOGIA MEDICO-CHIRURGICA, 2015, 55 (10) : 789 - 795
  • [24] Is Intravenous Recombinant Tissue Plasminogen Activator (r-tPA) Safe in Patients on Dabigatran?
    Govindarajan, Raghav
    Morren, John
    Galvez-Jimenez, Nestor
    NEUROLOGY, 2012, 78
  • [25] INTRAVENOUS ADMINISTRATION OF RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR - OPTIMIZING THE RATE OF CORONARY THROMBOLYSIS
    PREWITT, RM
    GU, SA
    SCHICK, U
    DUCAS, J
    CHEST, 1995, 107 (04) : 1146 - 1151
  • [26] Borderline Elevation of International Normalized Ratio and Use of Intravenous Recombinant Tissue Plasminogen Activator
    Aggarwal, Harsh R.
    Hassan, Ameer E.
    Rodriguez, Gustavo J.
    Suri, M. Fareed K.
    Lakshminarayan, Kamakshi
    Taylor, Robert A.
    Ezzeddine, Mustapha A.
    Qureshi, Adnan I.
    NEUROLOGY, 2010, 74 (09) : A511 - A511
  • [27] Acute Central Retinal Artery Occlusion Treated with Intravenous Recombinant Tissue Plasminogen Activator
    Nowak, Richard J.
    Amin, Hardik
    Robeson, Kimberly
    Schindler, Joseph L.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2012, 21 (08):
  • [28] Streamlining the Process for Intravenous Tissue Plasminogen Activator
    Lawrence, Erin
    Merbach, Dawn
    Thorpe, Sherry
    Llinas, Rafael H.
    Marsh, Elisabeth B.
    JOURNAL OF NEUROSCIENCE NURSING, 2018, 50 (01) : 37 - 41
  • [29] Intravenous tissue plasminogen activator and stroke in the elderly
    Longstreth, W. T., Jr.
    Katz, Ronit
    Tirschwell, David L.
    Cushman, Mary
    Psaty, Bruce M.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2010, 28 (03): : 359 - 363
  • [30] Hypersensitivity reactions to recombinant tissue plasminogen activator
    Alakbarzade, Vafa
    O'Kane, Declan
    Pereira, Anthony C.
    PRACTICAL NEUROLOGY, 2020, 20 (01) : 75 - +